We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
HHS Secretary Mike Leavitt today announced a contract award with GlaxoSmithKline to provide zanamivir (Relenza) to all 50 states, the District of Columbia, five U.S. territories and three Freely Associated States of the Pacific at a federally subsidized price.
The UK's Medicines and Healthcare Regulatory Products Agency (MHRA) has amended its Medicines for Human Use Regulations Good Clinical Practice (GCP) Directive.
Indian and foreign pharmaceuticals companies have joined forces to attack draft legislation that would extend significantly price controls on medicines and could remove the commercial case for investing in new drugs in the country.
The Hyderabad-based Vishnu Chemicals is setting up a manufacturing facility for chemicals and drugs in the Jawaharlal Nehru Pharma City (JNPC) in Parawada near Visakhapatnam with an investment of Rs 54 crore.
Avon-based Magellan Health Services Inc. has signed a definitive agreement to acquire ICORE Healthcare, a privately held specialty pharmaceutical management firm.
Trans Genic, a biotech company specializing in genome function research, and the Kumamoto Techno Industrial foundation have concluded an exclusive license agreement on anti-HIV antibodies PCT/JP2004/003046.
Mumbai-based USV Ltd, engaged in biotherapeutics, is all set to commercialise a new conjugate typhoid vaccine developed by a team of scientists at the All India Institute of Medical Sciences (AIIMS), New Delhi.
France's fourth largest pharmaceutical company by sales, Wednesday said it signed a licensing agreement with Swiss drugmaker Roche Holding AG for its diabetic treatment BIM 51077, which could net the company up to EUR229 million, excluding royalties.